Lexicon Pharma (LXRX) reported Q1 Revenue
Tweet
Share
E-mail
Get Alerts LXRX Hot Sheet
Price: $2.29 +3.15%
Revenue Growth %: -86.1%
Financial Fact:
Total operating expenses: 62.65M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: -86.1%
Financial Fact:
Total operating expenses: 62.65M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q1 Revenue for the quarter came in at $21.1 million versus the consensus estimate of $9.78 million.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Winnebago Industries (WGO) Misses Q3 EPS by 11c ; Offers Guidance
- Trip.com Group (TCOM) Misses Q1 EPS by 41c
- Deutsche Bank Starts Brunello Cucinelli SpA (BC:IM) (BCUCF) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
